PhaseRx

PhaseRx

PhaseRx

CEO of PhaseRx and former VC. PhaseRx is advancing mRNA therapeutics to treat orphan liver disease.
Founded
2006
Raised
$39.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$19,000,000
IPO - 2016
$20,216,583
Venture capital (Series A) - 2008
Team Size
1–10
Employees
GeekWire

PhaseRX sells to Riovant Sciences for $800,000 two months after declaring bankruptcy

Strategy Stock markets
GeekWire

PhaseRx liver disease drug receives boost from FDA, stock soars

Health
GeekWire

Geek of the Week: PhaseRx CEO Robert Overell is on a mission to save children with biotechnology

Science Technology